BR112012033625A2 - método e dispositivo para determinação do conteúdo das toxinas urêmicas ligadas na proteína e intermediárias em um fluido biológico - Google Patents
método e dispositivo para determinação do conteúdo das toxinas urêmicas ligadas na proteína e intermediárias em um fluido biológicoInfo
- Publication number
- BR112012033625A2 BR112012033625A2 BR112012033625A BR112012033625A BR112012033625A2 BR 112012033625 A2 BR112012033625 A2 BR 112012033625A2 BR 112012033625 A BR112012033625 A BR 112012033625A BR 112012033625 A BR112012033625 A BR 112012033625A BR 112012033625 A2 BR112012033625 A2 BR 112012033625A2
- Authority
- BR
- Brazil
- Prior art keywords
- bound
- protein
- uremic toxins
- determining
- content
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- General Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Optics & Photonics (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- External Artificial Organs (AREA)
Abstract
método e dispositivo para determinação do conteúdo das toxinas urêmicas ligadas na proteína e intermediárias em um fluido biológico. a presente invenção refere-se a um nomo método e um dispositivo para determinar toxinas urêmicas ligadas na proteína e intermediárias nos fluidos biológicos. mais especificamente, a presente invenção refere-se a um método ótico utilizando fluorescência, de preferência fluorescência do dialisado consumido e um modelo específico, incluindo um conjunto único de componentes espectrais óticos em determinados comprimentos de onda para determinar, de preferência em linha, a concentração das toxinas urêmicas ligadas na proteína e intermediárias, tais como beta2-microglobulina (b2m) e indoxil sulfato (is).
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EEP201000056A EE05676B1 (et) | 2010-06-28 | 2010-06-28 | Optiline meetod ja seade keskmise suurusega ja valkudega seotud ureemiliste toksiinide mramiseks bioloogilistes vedelikes |
| EEP201000085A EE05669B1 (et) | 2010-12-10 | 2010-12-10 | Optiline meetod ja seade keskmise suurusega ja valkudega seotud ureemiliste toksiinide mramiseks bioloogilistes vedelikes |
| PCT/EE2011/000008 WO2012000521A1 (en) | 2010-06-28 | 2011-06-28 | A method and device for determining content of the middle and protein bound uremic toxins in a biological fluid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012033625A2 true BR112012033625A2 (pt) | 2016-10-25 |
Family
ID=44508544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012033625A BR112012033625A2 (pt) | 2010-06-28 | 2011-06-28 | método e dispositivo para determinação do conteúdo das toxinas urêmicas ligadas na proteína e intermediárias em um fluido biológico |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9103789B2 (pt) |
| EP (1) | EP2585830B1 (pt) |
| JP (1) | JP5957450B2 (pt) |
| KR (1) | KR101848527B1 (pt) |
| CN (1) | CN102985822A (pt) |
| AU (1) | AU2011274009B2 (pt) |
| BR (1) | BR112012033625A2 (pt) |
| CA (1) | CA2837488C (pt) |
| NZ (1) | NZ605685A (pt) |
| WO (1) | WO2012000521A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102012112790A1 (de) * | 2012-12-20 | 2014-06-26 | B. Braun Avitum Ag | Verfahren und Vorrichtung zur Bestimmung von Abfallprodukten wie Indoxyl Sulfate in der Dialyse |
| WO2014129460A1 (ja) * | 2013-02-19 | 2014-08-28 | ユニチカ株式会社 | インドキシル硫酸の測定方法 |
| CN104991026A (zh) * | 2015-06-29 | 2015-10-21 | 苏州东辰林达检测技术有限公司 | 尿液中甲基马尿酸的检测方法 |
| EP3537135A1 (en) * | 2018-03-05 | 2019-09-11 | Tallinn University of Technology | A device and method for assessment of a concentration of free pentosidine in a spent dialysate |
| JP7207702B2 (ja) * | 2018-11-06 | 2023-01-18 | 国立研究開発法人農業・食品産業技術総合研究機構 | 成分抽出方法、蛍光指紋測定装置、及びコンピュータが実行可能なプログラム |
| TWI838830B (zh) * | 2022-04-08 | 2024-04-11 | 財團法人工業技術研究院 | β2-微球蛋白濃度的分析方法及裝置 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3261264B2 (ja) | 1994-07-13 | 2002-02-25 | 株式会社堀場製作所 | 多成分水溶液の分析方法およびその分析装置 |
| WO1998019592A1 (en) | 1996-11-01 | 1998-05-14 | Rio Grande Medical Technologies, Inc. | Dialysis monitoring method and apparatus |
| US6261848B1 (en) * | 1998-05-08 | 2001-07-17 | The Johns Hopkins University | Miniature immuno-optical rapid analyte sensor platform |
| SE525639C2 (sv) | 1998-06-04 | 2005-03-22 | Thore Falkvall | Bestämning av slaggprodukter i dialysvätska med hjälp av optisk sensor |
| AUPR748501A0 (en) * | 2001-09-04 | 2001-09-27 | Life Therapeutics Limited | Renal dialysis |
| US8337444B2 (en) * | 2001-05-22 | 2012-12-25 | Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California | Measurement of cardiac output and blood volume by non-invasive detection of indicator dilution for hemodialysis |
| RU2212029C1 (ru) | 2001-12-03 | 2003-09-10 | Общество с ограниченной ответственностью "Клиника экстракорпоральной гемокоррекции" | Способ анализа жидкой биологической среды в процессе мониторинга |
| US7002670B2 (en) * | 2002-06-12 | 2006-02-21 | Baxter International Inc. | Optical sensor and method for measuring concentration of a chemical constituent using its intrinsic optical absorbance |
| WO2005003744A1 (ja) * | 2003-07-03 | 2005-01-13 | Wako Pure Chemical Industries, Ltd. | 分光測定による特定成分の測定方法 |
| US7427508B2 (en) | 2003-10-09 | 2008-09-23 | Organotek Defense System Corporation | Method for assaying multi-component mixtures |
| WO2005069737A2 (en) * | 2004-01-27 | 2005-08-04 | Ramot At Tel Aviv University Ltd. | Method and system for detecting analytes |
| EP1751523B1 (en) | 2004-05-13 | 2017-10-04 | NarTest AS | A portable device and method for on-site detection and quantification of drugs |
| US7966051B2 (en) * | 2005-01-11 | 2011-06-21 | Olympus Corporation | Fluorescent agent concentration measuring apparatus, dose control apparatus, administration system, fluorescent agent concentration measuring method, and dose control method |
| DE102005020384A1 (de) * | 2005-05-02 | 2006-11-09 | Therainvention Gmbh | Spektroskopisches Verfahren zum Nachweis von Analyten |
| WO2009071102A1 (en) | 2007-12-04 | 2009-06-11 | Tallinn University Of Technology | Optical method and device for measuring concentrations of substances in biological fluids |
-
2011
- 2011-06-28 AU AU2011274009A patent/AU2011274009B2/en active Active
- 2011-06-28 KR KR1020137002066A patent/KR101848527B1/ko active IP Right Grant
- 2011-06-28 EP EP11740556.3A patent/EP2585830B1/en not_active Not-in-force
- 2011-06-28 NZ NZ60568511A patent/NZ605685A/en unknown
- 2011-06-28 CA CA2837488A patent/CA2837488C/en active Active
- 2011-06-28 BR BR112012033625A patent/BR112012033625A2/pt not_active Application Discontinuation
- 2011-06-28 WO PCT/EE2011/000008 patent/WO2012000521A1/en active Application Filing
- 2011-06-28 US US13/807,688 patent/US9103789B2/en active Active
- 2011-06-28 CN CN2011800323962A patent/CN102985822A/zh active Pending
- 2011-06-28 JP JP2013517023A patent/JP5957450B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2837488A1 (en) | 2012-01-05 |
| CN102985822A (zh) | 2013-03-20 |
| WO2012000521A1 (en) | 2012-01-05 |
| US20130193347A1 (en) | 2013-08-01 |
| EP2585830B1 (en) | 2018-04-25 |
| JP5957450B2 (ja) | 2016-07-27 |
| NZ605685A (en) | 2014-10-31 |
| EP2585830A1 (en) | 2013-05-01 |
| KR20130038347A (ko) | 2013-04-17 |
| CA2837488C (en) | 2021-10-26 |
| AU2011274009A1 (en) | 2013-01-31 |
| JP2013534630A (ja) | 2013-09-05 |
| AU2011274009B2 (en) | 2016-06-23 |
| KR101848527B1 (ko) | 2018-04-12 |
| US9103789B2 (en) | 2015-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012033625A2 (pt) | método e dispositivo para determinação do conteúdo das toxinas urêmicas ligadas na proteína e intermediárias em um fluido biológico | |
| BRPI0916624A2 (pt) | anticorpos monoclonais seletivos anti-hepcidina-25, seus usos, bem como método e kit para quantificar a quantidade de proteína hepcidina-25 em uma amostra de tecido ou fluido biológico | |
| EA201400491A1 (ru) | Сопровождающая диагностика для терапии с антигиалуроновым агентом и способы ее применения | |
| BRPI0715718A2 (pt) | Anticorpo, métodos de triar para um anticorpo para o domínio extracelular de uma proteína prlr, de alterar sistematicamente anticorpos e triar para um anticorpo para o domínio extracelular de uma proteína prlr, de tratar um indivíduo que sofre de câncer, de alvejar uma célula tumoral que expressa prlr, de usar uma célula hospedeira, de identificar um indivíduo com necessidade de tratamento com um anticorpo anti-prlr, e de monitorar terapia de câncer em um indivíduo, molécula de ácido nucleico isolada, vetor de expressão, célula hospedeira, composição farmacêutica, e, kit | |
| EP4332978A3 (en) | Analysis method for a biological sample | |
| BR112013021963A2 (pt) | sistema e método de separação de sangue para uma tira de teste seca | |
| EA201492106A1 (ru) | Способ и устройство для контроля экстракорпоральной обработки крови пациента | |
| MX2012000388A (es) | Prueba de equilibrio peritoneal simplificada para dialisis peritoneal. | |
| GB201007235D0 (en) | Taz/wwtr1 for diagnosis and treatment of cancer | |
| WO2013190075A3 (en) | Specific biomarkers for hepatocellular carcinoma (hcc) | |
| BR112013024190A2 (pt) | microdispositivo para detectar ou tratar doença e métodos para fabricar microdispositivo e para detectar doença em indivíduo em necessidade do mesmo | |
| MX2014001629A (es) | Sistema de tiempo de ejecucion. | |
| NZ608208A (en) | Breast cancer diagnostics | |
| BR112014003877A2 (pt) | biomarcadores de micro-rna e métodos de uso dos mesmos | |
| CY1112423T1 (el) | Αναλυτικη συσκευη μικροεπεξεργαστη μιας χρησης | |
| BR112014010067A8 (pt) | método e sistema para usar disparos de rastreador para estimar volumes de influxo de fluidos a partir de diferentes zonas de influxo para um fluxo de produção em um poço | |
| RU2013138721A (ru) | Способы и наборы для прогнозирования риска дыхательной недостаточности, почечной недостаточности или тромбопении у пациента, страдающего сепсисом, путем измерения уровней эндокана в крови | |
| CY1117838T1 (el) | Παραγοντες προβλεψης για θεραπευτικη αγωγη καρκινου | |
| BR112014024487A2 (pt) | métodos para aumentar a eficácia da terapia baseada em cd37 | |
| BR112012026361A2 (pt) | previsão de terapia e otimização de terapia sanguínea para insuficiência renal, especialmente hemodiálise domiciliar | |
| BR112012005670A2 (pt) | ''método para a identificação de um paciente com câncer que pode se beneficiar com a terapia antiagiogênica, método para a predição da responsividade de um paciente com câncer à terapia antiangiogênica, uso de um anticorpo anto- vegf para melhorar o efeito do tratamento de um paciente sofrendo de câncer, método ou uso, kit útil para realizar o método, uso de uma proteína ou usom kit útil para realizar o método, uso de uma proteína ou oligonucleotídeo ou matriz de polinecleotídeo para determinar o nível de expressão de bfgf em um método e kit ou uso | |
| BRPI0505096B8 (pt) | processo de separação por eletroforese capilar em solução livre (fsce) das hemoglobinas em amostras biológicas, utilização de um redutor de fluxo escolhido dentre diaminas alifáticas, poliaminas alifáticas, e seus derivados e sais aceitáveis, e suas misturas, e, kit de análise da hemoglobina para realizar o processo de separação das hemoglobinas em amostras biológicas por eletroforese capilar em solução livre (fsce) | |
| ATE475098T1 (de) | Verfahren zur messung von plasmaspiegeln von pentraxin ptx3 | |
| WO2008074029A3 (en) | Protein profile for osteoarthritis | |
| EP2732288A4 (en) | BIOLOGICAL MICROCHIP TO ESTIMATE THE CONCENTRATION OF IMMUNOGLOBULIN E AND G IN HUMAN BLOOD, TEST METHOD AND REAGENT SET THEREFOR |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: OUE OPTOFLUID TECHNOLOGIES (EE) |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |